chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous prospective pregnancy report was received from a nurse refers to a 35-year-old female patient. The patient pertinent medical history included high risk pregnancy due to age and had no drug reaction or allergies. The patient was pregnant with last menstrual period (LMP) of 12-JUN-2017 and estimated date of delivery (EDD) of 19-MAR-2018. Nurse reported that the patient, who was unaware she was pregnant, received a single dose of M-M-R II vaccine on 29-JUN-2017 by another clinic during immigration process for prophylaxis (indication reported as immigration'). Concomitant medications included calcium, prenatal vitamin and Ranitidine. After vaccination, she had no adverse effects and did not seek medical attention and treatment. The patient had complete blood count (CBC), Rubella, Urine test, Hepatitis B and C, Chlamydia Gonorrhea Blood typing with antibody, pap smear, human immunodeficiency virus (HIV) and the results were not reported. The outcome of pregnancy was pending at the time of report.
The day I got the vaccine was Day #1 of my period. I am not pregnant and no chance of being pregnant. My period vanished within 24 hours of getting the shot. I am on a pill and continued to take as normal.
Initial report received from a healthcare professional on 09 October 2013. A 61-year-old female patient, whose medical history and concomitant medications were not reported, had received an intradermal dose of FLUZONE ID, batch number - UT4721BA dose number was not reported in left deltoid on 07 October 2013. On 08 October 2013, one days after vaccination the patient experienced mild swelling, 6cm redness and a fine raised rash around the injection site. Patient also experienced in left deltoid area that went to her left armpit. Patient received cold compresses, topical application of hydrocortisone and bacitracin ointment as corrective treatments and laboratory investigations were not reported. At the time of this report, the outcome of the events was unknown. Documents held by sender: none.
This spontaneous report as received from a Licensed Practical Nurse refers to a 17 year old female patient with no medical history and no drug reactions/allergies. On 09-APR-2014 the patient was vaccinated with VARIVAX (Merck) (Lot# reported as J009166 and unspecified expiration date), 0.5 ml, subcutaneous. Concomitant therapies included ADDERALL. On 22-APR-2014, the patient was seen in the office with a "generalized rash all over her body". The patient had blood drawn at an unspecified LabCorp on 23-APR-2014. The nurse stated they received the results of the blood work on 24-APR-2014 which showed "varicella zoster IgG was low at less than 135 and varicella zoster IgM was high at 1.68". The nurse stated "our physicians determined that the rash was a reaction to the varicella vaccine and not a reported case of chickenpox". When asked the patient's present status the nurse stated, "we told her to call if things worsened or if it didn't go away in a few days. We haven't heard back from her". No treatment was given for the event. Additional information has been requested.
Patient was born on August 20, 2009 and received a Pfizer Covid 19 vaccine on 5/23/21, when patient was not 12 years old.
*Immunized arm is still sore, with red welts and pt. is very fatigued *Told patient to try cortisone, Benadryl and ice.
Patient received Covid-19 Pfizer vaccine on 04/28/21. Patient received Menveo 0.5ml on 05/05/2021.  I was unaware the patient received the covid vaccine until his mother told me after the menveo vaccine had already been given. Patient has not had any adverse reaction, but representative instructed to have VAERS form sent in since covid vaccine has not received an official FDA approval.
symptoms of COVID-19; Fatigue; Loss of taste; Loss of smell; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), COVID-19 (symptoms of COVID-19) and FATIGUE (Fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced AGEUSIA (Loss of taste), ANOSMIA (Loss of smell) and FATIGUE (Fatigue). On 29-Mar-2021, the patient experienced COVID-19 (symptoms of COVID-19). At the time of the report, AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), COVID-19 (symptoms of COVID-19) and FATIGUE (Fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Patient came back to the pharmacy 5 days later to report redness/swelling around the area. Went to doctor for pain, muscle ache. Still swollen/red.
pt reports severe rt shoulder joint pain post vax;pt expected some soreness p/each vax but not lasting this long;it was so bad during a mission that pt had to stand up to throw switches;
Patient complained of being dizzy, lightheaded, tingling sensation all over, and having to concentrate on breathing. The patient waited in the store for 15 minutes and felt fine afterwards. The next day, the patient reported shortness of breath and difficulty breathing while running only. No treatment given. patient experiencing symptoms while running only No symptoms while performing normal activity.
Information has been received from a 62 year old male who "about 8 weeks ago" was vaccinated with single dose of series of ZOSTAVAX (Oka/Merck) and now the patient has genital herpes. At time of the report the patient's genital herpes outcome was unknown. The patient sought unspecified medical attention. Additional information has requested.
Body aches, fever 100.7, vertigo, Headache, pain radiating from injection site up to ear, pale, weakness.
Patient was in office for follow up visit where he asked to receive covid booster (Pfizer Bivalent)  and flu vaccine. The current employee health nurse was in office for vaccine clinic for employees and had used up the vial of the Bivalent vaccine that was originally opened and handed over fresh vial of vaccine that they had pulled from the vaccine fridge. However this vial was for Pfizer Primary vaccine and not for the Pfizer Bivalent vaccine. Patient was given Pfizer Primary instead of the Bivalent. Mistake was not caught until after vaccine was given and went to document . Provider who had seen patient was notified and has been trying to contact patient to inform them of the incorrect vaccine administration and the next steps.
Within 12 hours of of booster shot, as well as the first injection (March 2021), oral cold sores appeared on the lips. This happened in spite of individual being on daily valtrex medication for the prevention of cold sores.
vaccine_brand_other=Moderna; Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 19Sep2022 as dose 5 (booster), single (Lot number: GH9694) at the age of 69 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 19Feb2021 as dose 2, single (Lot number: IN6203), in left arm and on 30Sep2021 as dose 3 (booster), single (Lot number: FF8839), in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 18Apr2022 as dose 4 (booster), single (Lot number: 001M21A), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Thyroidectomy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 07Feb2023, outcome "unknown" and all described as "Treatment of COVID-19"; INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "vaccine_brand_other=Moderna". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (unspecified date) Positive; (07Feb2023) Positive; (15Feb2023) Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient initially tested positive for COVID-19 on 07Feb2023. She started taking PAXLOVID that same evening and finished the course on 12Feb2023. Because her kidney function tests were somewhat low, her doctor instructed her to take only one of the nirmatrelvir tablets. She tested negative for the first time on 15Feb2023. On 17Feb2023, she started feeling like she was getting a cold. She did two rapid tests from two different manufacturers, and they were both positive. Concomitant medication active drug substance included Antihistamine/Decongestant and Multivitamins. Patient had no known allergy.
got Covid but she did not mention if it was before or after first shot; cannot feel her taste 100%; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got Covid but she did not mention if it was before or after first shot) and AGEUSIA (cannot feel her taste 100%) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (got Covid but she did not mention if it was before or after first shot) and AGEUSIA (cannot feel her taste 100%). At the time of the report, COVID-19 (got Covid but she did not mention if it was before or after first shot) and AGEUSIA (cannot feel her taste 100%) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided No treatment medications provided
She developed generalized itching, hives, left arm pain, and chest pain 2 hours after receiving vaccine.  Symptoms caused patient to seek treatment in the Emergency Department.   Patient experience syncopal episode while in the ED and the following day while at home.
1.  Sore Arm, 2.  Swollen Lymph Node in Right armpit area, and 3. The following menstrual period was different than usual.  It was longer than usual (12 days of bleeding, when normally 5-7), and the cycle was the longest (44 days) I have ever had.  Ovulation was delayed by a week, as well (I use Luteinizing Hormone tests every month, as I am trying to conceive).  Cycles are normally 28-30 days, like clockwork, so 44 days is very long for me.  Also, menstrual cramps were more painful than usual.
Developed soreness and muscle firmness 1-2 inches under vaccination site within a few hours post-vaccination. Within 12 hours after administration, a red rectangular rash with warmth developed on skin in same location. 48 hours post-vaccine, soreness subsided but rash/warmth is still present.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. The patient was vaccinated with GARDASIL for the first time in 2007 and received a second dose in 2009. This is considered an inappropriate schedule of drug administration. No adverse effect was reported. Patient route of administration and lot no. information were not reported. No other co-suspects were reported. No concomitant medications were reported. Additional information is not expected.
Initial report received on 26 March 2007 from the patient. A female patient (demographic not provided) had received an INFLUENZA VACCINE, sometime in December 2003. The trade name, manufacturer, lot number, route and site of administration not provided. The next day, the patient woke with her left "shoulder on fire", left rib hurt, left buttock hurt and left foot hurt. The symptoms have progressed to being "Totally crippled in my left leg for the next two years". The patient reports that she has been "frozen with massive swelling in my neck, jaw, right foot and hands which throb and is very painful". The patient indicated she had to go on disability. The patient has been to many doctors and has been prescribed many medications. The medications are only "band-aids, the culprit never goes away." The patient was subsequently diagnosed with reactive arthritis. The patient was told she would recover, but it would be a very slow recovery. The patient stated that "I am very slowly getting better, but this has ruined my life over the past thee years." She has been "almost a house-bound vegetable for the last two years". The patient is recovering.
This spontaneous report was received from a physician via company representative refers to two patients of unknown age (gender unspecified). Approximately on an unknown date in 2008 (reported as occurred 5 years ago), the patient were vaccinated with a dose of ZOSTAVAX, (lot number, expiration date and route not reported). No concomitant medfivations were reported. Approximately on an unknown date in 2008, the patients developed rashes and a few lesions on their arms after being vaccinated with ZOSTAVAX. Treatment rendered for the event was antiviral medication. The patient sought medical attention. This is one of the two reports received from the same reporter. Additional information is not expected.
On 4/29/21 patient called to inform me that she was having a "swollen armpit" in her COVID19 vaccine arm. I explained it was probably due to her lymph node in that arm working extra hard. We discussed taking ibuprofen and marking how swollen it is now and to see her PCP if the swelling gets any worse. Her vaccine occurred on 04/27/2021
Information has been received from a physician concerning an 18 year old female with no pertinent medical history or drug reactions/allergies, who on 03 Nov 2006 was vaccinated with Gardasil (yeast) (0.5 ml). There was no concomitant medication. On 03 Nove 2006 the patient experienced shortness of breath, chest pain, chest tightness and numbness in the arm that lasted approximately 30 minutes. Unspecified medical attention was sought. Additional information has been requested.
Headache, Myalgia & Fever Narrative: headache, chills, fever, severe myalgia
The patient immunocompromised got booster dose instead of third dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (The patient immunocompromised got booster dose instead of third dose) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 19-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, the patient experienced INCORRECT DOSE ADMINISTERED (The patient immunocompromised got booster dose instead of third dose). At the time of the report, INCORRECT DOSE ADMINISTERED (The patient immunocompromised got booster dose instead of third dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment medication information provided.
Pt. was given YF vaccination SQ in fatty posterior of R arm.  After 3 minutes, injection site was red and swollen the size of a nickel. I went and gave patient 2 tabs of IBUPROFEN P.O.; Ice pack was applied to the site. MA gave the Patient BENADRYL 50 mg PO. as per RN, we had pt. lay down for 20 minutes.  Pt. was checked at frequent intervals after the 20 minutes RN went in the room w/me to check on the patient.  Pt. was requested to sit up, his skin color looked good and he stated he had no symptoms and that he felt fine, Pt. was released and left the office.
Dose administered after temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after temperature excursion) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after temperature excursion). On 17-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Dose administered after temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.   The reporter stated that she had 2 vials that were in freezer and gone temperature excursion due to a power outage.  Treatment information was not provided.
Numbness on the left cheek, nose; Numbness on the left cheek, nose and lip; Tingling; This is a spontaneous report from a non-contactable consumer, the patient. A 64-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: er2613), via an unspecified route of administration in the left arm on 24Mar2021 at 09:00 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. Medical history included spice allergy (garlic). The patient did not take any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 24Mar2021 at 10:00, the patient experienced tingling, followed by numbness on the left cheek, nose and lip. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events tingling, numbness and numbness lip was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
1) Three weeks after receiving my first dose of the AstraZeneca Vaccine, I experienced severe burning, numbness, tingling, pain, and some altered sensation on the entire left side of my body, as well as weakness in my left side. The sensations are felt in my left arm, leg, side of torso, foot, hand, and neck. The pain, burning, and tingling are strongest in my left arm and left leg (from hip down), and weakness is most pronounced in my left arm and left hand. I am now having trouble typing with my left hand as well (worsened dexterity in my left hand). I am also experiencing extreme fatigue and exhaustion, and a general sense of malaise. After a week of my symptoms, I consulted a neurologist, who immediately ordered an MRI of my head and cervical spine with and without contrast. As read by that doctor, the MRI was considered clean. The symptoms have not improved over the three weeks, and have significantly worsened. The symptoms are severe and incapacitating enough to keep me from doing my every day activities.   2) Two days after receiving the vaccine I experienced impaired taste and smell. The most acute impairment lasted for about a week, and it slowly improved. In that time period, I took two COVID-19 PCR tests (both negative) to rule out COVID infection (I also had a negative PCR test just before vaccination as well). I still have a slightly altered taste and smell.
This patient had a severe onset of localized reaction that began approximately 6 hours post injection. Initially painful adduction of the left arm with gradual increasing erythema and induration at the left deltoid; measuring 70 mm x 60 mm (induration).
5 minutes after injection tingling/burning sensation came across both arms and entire upper body. Tachycardia and palpitations followed within the hour. 5 days later bleeding from vagina; not related to menses. Back pain and abdominal pain, calf muscle pain, sleep disturbances, sinusitis and chronic body pain. Now cannot function normally. Have lost 25 pounds.
3-4 hrs after injection R arm became numb with progressive pain radiating into neck and down to finger tips. Severe pain and complete limitation of the R arm followed.  ER visit was within 24 hrs, with slow recovery over next 48-72 hrs.
first Covid vaccine today.  She does have a history of passing out with blood draws her in injections.  She got her vaccination, went to sit down, felt hot, nauseated and lightheaded and the next thing she knew people were around her and someone was putting oxygen on her.  Afterwards she had a mild amount of chest pressure but not before.
Developed tendonitis and severe pain in arm. In hospital for short stay but out of commission with arm for about 1 week.
About 6 hrs after patient received vaccine, the patient realized the site vaccine was given was itchy and red. Family called the office to discuss. Pt denied any signs of distress. Only complaint was itching at the site of vaccine. Reviewed symptoms with patient's PCP and advised cold pack and topical hydrocortisone cream for itching and if persists, oral antihistamine.
8JUN94 body rash x 4 days, & fever, cough, rhinorrhea-dx folliculitis & URI; 22JUN94 heat type rash, cough, fever, dec appetite; dry heaves r/o sepsis, meningitis, folliculitis; adm to hosp-stayed overnoc; dx impetigo, URI
6hrs post vax pt devel fever of 104C & became very limp for approx 4-6hrs; (described like was drunk);
Facial eczema in remission for many years, resurfaced after the second dose of vaccine; This is a spontaneous report from a contactable Physician (patient). A 49-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EN9581) via unknown route administered in Arm Left on 04Feb2021 (at the age of 49 years old) as dose 2, single for COVID-19 immunisation. The patient medical history included Facial eczema. The patient did not have allergies. The concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: El3246) via unknown route administered in Arm Left on 13Jan2021 at 01:00 PM (at the age of 49 years old) as dose 1, single for COVID-19 immunisation. The patient did not receive other vaccine in four weeks. On 18Feb2021 at 01:00 PM, the patient experienced Facial eczema in remission for many years, resurfaced after the second dose of vaccine. Patient did not receive treatment for the event.  The patient did not have covid prior vaccination and not tested for covid post vaccination. The outcome was not recovered.  Follow-up attempts completed. No further information expected.